drugset / Trial / NCT00540527

Local Versus Systemic Thrombolysis for Acute Ischemic Stroke (SYNTHESIS)

NCT00540527 ↗

Phase 3 Completed 54 enrolled Niguarda Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether intra-arterial rt-PA within 6 hours from an ischemic stroke onset, compared with intravenous infusion of the same drug within 3 hours, increases the proportion of independent survivors at 3 months.

Timeline

Start
2004-01
Primary completion
2008-01
Completion
2008-01

Outcome

Missed primary endpoint

paper Almost twice as many patients on IAT as those on IVT survived without residual disability (12/25 vs 8/29; OR 3.2; 95% CI 0.9 to 11.4; p=0.067). PMID 21990564 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic 0.9 mg/kg Other

Indications